MAP2K1 and malignant colon neoplasm: PCDH7 provides a potential therapeutic strategy in colon cancer: it can inhibit the MEK1/2/ERK/c-Fos axis by knocking down PCDH7, induce neurogenesis and autophagy, and enhance the effect of colon cancer cells on chemotherapy30.